Jan M. Horáček

763 citations
50 papers · 498 indexed · h-index 15
Topics
Chemotherapy-induced cardiotoxicity and mitigation (12 papers)Acute Myeloid Leukemia Research (11 papers)Cancer Treatment and Pharmacology (11 papers)

In The Last Decade

Jan M. Horáček

41 papers receiving 484 citations

Peers

Jan M. Horáček
Comparison fields: 5 of 73
  • Cardiology and Cardiovascular Medicine 273
  • Oncology 179
  • Hematology 106
  • Molecular Biology 65
  • Pulmonary and Respiratory Medicine 60
Replace Ladislav Jebavý with:
Ladislav Jebavý Czechia
Beáta Mladosievičová Slovakia
Stacy Epstein United States
Eleonora Arboscello Italy
Q.H. Le France
Mustafa Dikilitaş Türkiye
Ghandi Damaj France
Brian Bird Ireland
Rupal O’Quinn United States
James C. Wernz United States
Jan M. Horáček relative to Ladislav Jebavý Czechia Ladislav Jebavý's profile →
Citations per field
00.5×1.5×1.8×
Ladislav Jebavý · 1×
Citations per year

Countries citing papers authored by Jan M. Horáček

Since Specialization
Citations

This map shows the geographic impact of Jan M. Horáček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan M. Horáček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan M. Horáček more than expected).

Fields of papers citing papers by Jan M. Horáček

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan M. Horáček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan M. Horáček. The network helps show where Jan M. Horáček may publish in the future.

Co-authorship network of co-authors of Jan M. Horáček

This figure shows the co-authorship network connecting the top 25 collaborators of Jan M. Horáček. A scholar is included among the top collaborators of Jan M. Horáček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan M. Horáček. Jan M. Horáček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 0
5 1
6 0
7 2
8 10
9 4
10 8
11 8
12 24
13 8
14 8
15 5
16 45
17 1
18
[Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience].
7
19
Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
15
20
[Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology].
4

About Jan M. Horáček

Jan M. Horáček is a scholar working on Hematology, Oncology and Cardiology and Cardiovascular Medicine, having authored 50 papers that have together received 498 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Acute Myeloid Leukemia Research (11 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (273 citations), Hematology (106 citations) and Oncology (179 citations). Jan M. Horáček has collaborated with scholars based in Czechia, Serbia and United States. Frequent co-authors include Ladislav Jebavý, Radek Pudil, J Malý, M. Tichý, Павел Зак, Martin Jakl, Jan Vojáček, Tomáš Büchler, Cyril Šálek and Vladimír Palička. Their work appears in journals such as Blood, Nutrients and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026